메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술대회자료
저자정보
Chul Seung Lee (The Catholic University of Korea) In Kyu Lee (The Catholic University of Korea)
저널정보
대한종양외과학회 대한임상종양학회 학술대회지 대한종양외과학회 2021 Seoul International Symposium of Surgical Oncology [초록집]
발행연도
2021.6
수록면
204 - 204 (1page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Background/Aims
Adjuvant chemotherapy in patients with high-risk stage II and III colorectal cancer prevents recurrence by eliminating minimal residual disease. However, patients who are at high risk of recurrence after completing standard adjuvant therapy are currently unknown. Although ascites CEA level has been associated with long-term oncologic outcomes, the clinical significance of ascites CEA in high-risk stage II and stage III colorectal cancer (CRC) has not yet been described. The present study aimed to determine the long-term oncologic impacts of ascites CEA level after curative colorectal cancer.

Methods
Between January 2015 and December 2018, medical records of 909 patients who underwent minimally invasive surgery (robotic or laparoscopic) for colorectal cancer at Seoul St. Mary’s Hospital, The Catholic University of Korea were reviewed. We excluded cases with a pathologically confirmed of other malignancy or cases with concomitant operations. We excluded 651 cases of stage 0, I, low risk II and IV cancer and 477 target diseases included in this study were high-risk stage II and stage III colorectal cancer, proven on permanent pathology report.
At the beginning of the operation, if more than 2 ml of ascites was found, the sample was collected by syringe aspiration. Cytology and tumor marker analysis we ... 전체 초록 보기

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2021-514-001919758